We are recruiting! 🥼 Scientific Officer to work with @drwilliamhill.bsky.social 💻 Computational Immunologist in the lab of @santiagozelenay.bsky.social 📝 Executive Assistant to our new Institute Director Prof Samra Turajlić @turajliclab.bsky.social Details at: www.cruk.manchester.ac.uk/careers/

We are delighted to announce, along with Cancer Research UK (@cancerresearchuk.org), The University of Manchester (@manchester.ac.uk) and The Christie NHS Foundation Trust, the appointment of Professor Samra Turajlić as our new Director! ⭐ Full story here: www.cruk.manchester.ac.uk/news/profess...

We are recruiting a #postdoctoral researcher for our Cancer Inflammation and Immunity group headed by @santiagozelenay.bsky.social For all the project details, research background, information about the position and the Institute, please visit: www.cruk.manchester.ac.uk/career/mi-25...

And learn more about the role and how to apply here: www.cruk.manchester.ac.uk/career/mi-25... Please share with anyone who might be interested!

Interested in investigating the principles that regulate the establishment of tumour environments that promote or inhibit the anti-tumour function of the immune system? Our group is currently recruiting a postdoctoral fellow. Learn more about our research 👇 www.cruk.manchester.ac.uk/research-gro...

I am excited to share our study showing how the immune system strikes a delicate balance between tolerating food and defending against helminth infections. www.science.org/doi/10.1126/....

Interesting work, it's becoming clear that @santiagozelenay.bsky.social's 2015 work on the COX-PGE axis' role in tumor immune evasion is robust (and also that we really need to focus on type I IFN in anti-tumor immunity). #Immunology #Immunotherapy #Immunosky

But because, as many people like to complain, nothing in immunology is simple, Ifn gamma also has an important role to play www.cell.com/immunity/ful...

⏰ Final call! 🧑‍🔬 Last week to apply for this fantastic opportunity to work with the exceptional @giampazolias.bsky.social at @cruk-mi.bsky.social. #TeamManchester To apply (deadline 1 Dec 2024): www.cruk.manchester.ac.uk/recruitment/...

Are so-called 'M2-like' CD206+ macrophages immunosuppressive? On the contrary, we find that they are critical for T cell mediated anti-tumor immunity. Arja Ray drove this study with help from Ken Hu, Kelly Kersten, Alexis Combes and others www.biorxiv.org/content/10.1...

We’ve renewed funding for our Lung Cancer Centre of Excellence for the next 5 years! With up to £4m support from our partner ScottishPower, researchers will continue to find new ways to beat #LungCancer 👇 @cruk-mi.bsky.social @thecrick.bsky.social news.cancerresearchuk.org/2024/11/20/4...

Enjoying an izakaya with Santiago Zelenay in Kyoto, a Demengeot lab reunion.

The final event of the CCII-Kyoto inaugural symposium: a workshop for students/postdocs on #immunity #Metabolism #inflammation & #ageing with Hongbo Chi, Santiago Zelenay & Osamu Takeuchi #Immunology www.ccii.med.kyoto-u.ac.jp/en/

💥Exciting #ERCResearch funded postdoc opportunities in my lab at @cruk-mi.bsky.social to study #NutrientHostMicrobiome interactions in #CancerImmunity in mice and humans. #CancerImmunology#MucosalImmunology#Microbiome ⏰Deadline: 1 December 2024 Apply👇 www.cruk.manchester.ac.uk/recruitment/... ⏩RT